3,330
Views
4
CrossRef citations to date
0
Altmetric
Editorial

New treatments for ulcerative colitis: do we have pediatric data?

, &
Pages 701-704 | Received 07 Mar 2016, Accepted 08 Apr 2016, Published online: 26 Apr 2016
 

Declaration of Interests

RK Russell has received speaker’s fees, travel support, or participated in medical board meetings with MSD Immunology, Nestle, AbbVie,Dr Falk, Janssen, Takeda and Napp. R Hansen has received speaker’s fees, travel support, or consultancy fees with MSD Immunology, Nutricia, Dr Falk, and 4D Pharma. In the last 3 years D Turner received consultation fee, research grant, royalties, or honorarium from Janssen, Pfizer, SickKids, Ferring, MegaPharm, AstraZeneca, Abbvie, Takeda, BMS, Rafa, Boehringer Ingelheim, Biogen, Atlantic Health. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.